drugset / Trial / NCT04623840
Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
Erectile dysfunction (ED) is the persistent inability to attain and maintain a sufficient erection to permit satisfactory sexual performance. ED, a condition closely related to cardiovascular morbidity and mortality, is frequently associated with obesity. The importance of reducing cardiovascular risk factors remains fundamental to the overall vascular good health of the man, and that includes sexual vascular health. ED shares similar modifiable risks factors with coronary artery disease (CAD). Lifestyle modification that targets CAD risk factors may also lead to improvement in ED.
Timeline
- Start
- 2020-10-12
- Primary completion
- 2021-02-28
- Completion
- 2021-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tadalafil | Small molecule | 5 mg | — |